Author:
Cui J,Sun D,Lu H,Dai R,Xing L,Dong H,Wang L,Wei D,Jiang B,Jiao Y,Jablonski M M,Charles S,Gu W,Chen H
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 2004; 122: 477–485.
2. Ye H, Zhang Q, Liu X, Cai X, Yu W, Yu S et al. Prevalence of age-related macular degeneration in an elderly urban chinese population in China: the Jiangning Eye Study. Invest Ophthalmol Vis Sci 2014; 55 (10): 6374–6380.
3. Souied E, Kaplan J, Coscas G, Soubrane G . Age-related macular degeneration and genetics J. J Fr Ophtalmol 2001; 24 (8): 875–885.
4. Vedula SS, Krzystolik MG . Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degeneration. Cochrane Database Syst Rev 2008; 16: CD005139.
5. Berg K, Pedersen TR, Sandvik L, Bragadóttir R . Comparison of ranibizumab and bevacizumab for neovascular age-related macular degeneration according to LUCAS treat-and-extend protocol. Ophthalmology 2015; 122: 146–152.
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献